Medicare is headed for a more expensive 2027, as new federal data show rising prescription drug spending, higher Part D premiums and early warnings of benefit cuts across Medicare Advantage plans.
Demand for medications is surging partly because of innovations and partly because of changes in the law. ARTICLE